1. Home
  2. STRA vs NTLA Comparison

STRA vs NTLA Comparison

Compare STRA & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$78.67

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$14.10

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
NTLA
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
STRA
NTLA
Price
$78.67
$14.10
Analyst Decision
Buy
Buy
Analyst Count
2
18
Target Price
$96.50
$18.34
AVG Volume (30 Days)
220.2K
3.3M
Earning Date
01-01-0001
05-21-2026
Dividend Yield
3.16%
N/A
EPS Growth
60.48
3.14
EPS
3.76
N/A
Revenue
$997,137,000.00
$57,877,000.00
Revenue This Year
$5.99
$1.71
Revenue Next Year
$3.79
N/A
P/E Ratio
$20.21
N/A
Revenue Growth
57.23
59.55
52 Week Low
$72.17
$5.90
52 Week High
$92.98
$28.24

Technical Indicators

Market Signals
Indicator
STRA
NTLA
Relative Strength Index (RSI) 49.25 62.28
Support Level $73.81 $10.44
Resistance Level $81.59 $14.61
Average True Range (ATR) 2.67 0.79
MACD -0.02 0.10
Stochastic Oscillator 66.70 98.97

Price Performance

Historical Comparison
STRA
NTLA

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: